Table Serial pulmonary function test results showing a marked improvement in vital capacity (VC) and total lung capacity (TLC) from the initial baseline levels after stopping co-proxamol therapy. Little change in carbon monoxide transfer factor (Kco) was, however, seen

DateTLC (l)VC (l)KCO (mmol/min/kPa/l)
13 May 935.704.301.05
06 Sep 935.153.750.96
08 Nov 935.603.950.86
17 Jan 946.154.051.03
26 Jan 956.855.301.05
Predicted6.3 ± 0.84.2 ± 0.71.42 ± 0.27